330213-81-5

Upstream product

• 118-46-7 8-amino-2-naphthol 
• 100-39-0 benzyl bromide 
• 301548-32-3 t-butyl (7-hydroxynaphthalen-1-yl)carbamate 
• 1443320-60-2 (7-benzyloxy-naphthalen-1-yl)-carbamic acid tert-butyl ester 

Downstream Products

• 849109-71-3 7-benzyloxy-1-iodo-naphthalene 
• 849109-76-8 8-(2-phenyl-5-pyridin-4-yl-3H-imidazol-4-yl)-naphthalen-2-ol 
• 849109-51-9 phenyl-carbamic acid 8-(2-phenyl-5-pyridin-4-yl-3H-imidazol-4-yl)-naphthalen-2-yl ester 
• 1443321-05-8 N-(7-benzyloxynaphthalen-1-yl)(tert-butoxycarbonylamino)acetamide 
• 402924-48-5 1-(7-(benzyloxy)-1-naphthyl)-2(1H)-quinolinone 

Relevant academic research and scientific papers

COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS

The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly di

Inhibitors of prenyl-protein transferase

The present invention is directed to peptidomimetic macrocyclic compounds which inhibit prenyl-protein transferase and the prenylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds

Amino (oxo) acetic acid protein tyrosine phosphatase inhibitors

Compounds of formula (I) or therapeutically acceptable salts thereof, are protein tyrosine kinase PTP1B inhibitors. Preparation of the compounds, compositions containing the compounds, and treatment of diseases using the compounds are disclosed.